In conclusion, we showed that intratumoral immunotherapy based on the application of mannan-BAM, TLR ligands, and anti-CD40 antibody (MBTA therapy) exhibits the potential to suppress tumor growth in a murine bilateral pheochromocytoma model. This evidence concerns the gene CD40 and pheochromocytoma.